Investigations into the synthesis, radiofluorination and conjugation of a new [18F]fluorocyclobutyl prosthetic group and its in vitro stability using a tyrosine model system
摘要:
The [F-18]fluorocyclobutyl group has the potential to be a metabolically stable prosthetic group for PET tracers. The synthesis of the radiolabeling precursor cis-cyclobutane-1,3-diyl bis(toluene-4-sulfonate) 8 was obtained from epibromohydrin in 7 steps (2% overall yield). The radiolabeling of this precursor 8 and its conjugation to L-tyrosine as a model system was successfully achieved to give the new non-natural amino acid 3-[F-18]fluorocyclobutyl-L-tyrosine (L-3-[F-18]FCBT) [F-18] 17 in 8% decay-corrected yield from the non-carrier-added [F-18] fluoride. L-3-[F-18] FCBT was investigated in vitro in different cancer cell lines to determine the uptake and stability. The tracer [F-18] 17 showed a time dependent uptake into different tumor cell lines (A549, NCI-H460, DU145) with the best uptake of 5.8% injected dose per 5 x 10(5) cells after 30 min in human lung carcinoma cells A549. The stability of L-3-[F-18] FCBT in human and rat plasma and the stability of the non-radioactive L-3-FCBT in rat hepatocytes were both found to be excellent. These results show that the non-natural amino acid L-3-[F-18] FCBT is a promising metabolically stable radiotracer for positron emission tomography. (C) 2012 Elsevier Ltd. All rights reserved.
This invention relates to novel cyclo alkyl compounds suitable for labeling by
18
F, methods of preparing such a compound, compositions comprising such compounds, kits comprising such compounds or compositions and uses of such compounds, compositions or kits for diagnostic imaging by positron emission tomography (PET).
Investigations into the synthesis, radiofluorination and conjugation of a new [18F]fluorocyclobutyl prosthetic group and its in vitro stability using a tyrosine model system
作者:Dominic Franck、Torsten Kniess、Jörg Steinbach、Sabine Zitzmann-Kolbe、Matthias Friebe、Ludger M. Dinkelborg、Keith Graham
DOI:10.1016/j.bmc.2012.11.049
日期:2013.2
The [F-18]fluorocyclobutyl group has the potential to be a metabolically stable prosthetic group for PET tracers. The synthesis of the radiolabeling precursor cis-cyclobutane-1,3-diyl bis(toluene-4-sulfonate) 8 was obtained from epibromohydrin in 7 steps (2% overall yield). The radiolabeling of this precursor 8 and its conjugation to L-tyrosine as a model system was successfully achieved to give the new non-natural amino acid 3-[F-18]fluorocyclobutyl-L-tyrosine (L-3-[F-18]FCBT) [F-18] 17 in 8% decay-corrected yield from the non-carrier-added [F-18] fluoride. L-3-[F-18] FCBT was investigated in vitro in different cancer cell lines to determine the uptake and stability. The tracer [F-18] 17 showed a time dependent uptake into different tumor cell lines (A549, NCI-H460, DU145) with the best uptake of 5.8% injected dose per 5 x 10(5) cells after 30 min in human lung carcinoma cells A549. The stability of L-3-[F-18] FCBT in human and rat plasma and the stability of the non-radioactive L-3-FCBT in rat hepatocytes were both found to be excellent. These results show that the non-natural amino acid L-3-[F-18] FCBT is a promising metabolically stable radiotracer for positron emission tomography. (C) 2012 Elsevier Ltd. All rights reserved.